CACLP - The largest IVD Expo & Conference

Meridian Bioscience Nabs FDA EUA for Revogene SARS-CoV-2 Test

Industry news | 11 November, 2021 | CACLP

Original from: Genomeweb


Meridian Bioscience announced on Wednesday that its Revogene SARS-CoV-2 test has received Emergency Use Authorization from the US Food and Drug Administration. 


The molecular test runs on the firm's Revogene instrument and returns positive results in 47 minutes and negative results in 70 minutes from a nasopharyngeal, oropharyngeal, anterior nasal, or mid-turbinate nasal swab. Both the test's positive and negative predictive agreements are 97.7 percent, the company said in a statement. 


Cincinnati-based Meridian said it expects to begin shipping the test before the end of the calendar year. 


"There continues to be high demand for fast, accurate detection of COVID-19 especially considering the upcoming respiratory season and combating the COVID-19 variants that continue to emerge," Tony Serafini-Lamanna, Meridian's executive VP for diagnostics, said in a statement. The Revogene test can help meet those demands, he added.


In February, the FDA requested additional information for Meridian's EUA application for the test, and later that month the firm announced it would withdraw its application to conduct additional studies on the test. 


Meridian resubmitted its application to the FDA in June after conducting a new clinical validation study and limit-of-detection bridging study.

Filed under:
Press contact CACLP - The largest IVD Expo & Conference

Stay in touch with CACLP News

We deliver the latest IVD news straight to your inbox. Stay in touch with CACLP News, sign-up for our newsletter today.

  • Name *
  • Email *
  • Company name *
  • Country *
    CACLP - The largest IVD Expo & Conference

By subscribing our newsletter, you agree to our Privacy Policy. You can unsubscribe at anytime.

Share
Opening Countdown
0 0 0

Day(s)

0 0

Hour(s)

0 0

Min(s)

Room 2201-2203 & 2205, Cloud Nine Plaza
1118 West Yan’an Road
Shanghai, China
200052

Copyright © 2024 GL events Ruihe (Shanghai) Exhibition Co., Ltd. All Rights Reserved. ( 沪ICP备12004745号-1 )

We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy & Cookies for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

CACLP - The largest IVD Expo & Conference